Reply to the Letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Publication date: Available online 23 May 2020Source: Diabetes & Metabolic Syndrome: Clinical Research & ReviewsAuthor(s): Awadhesh Kumar Singh, Ritesh Gupta, Anoop Misra
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research